Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early intervention Chinese medicine for acute ischemic stroke
ChiCTR-OPC-16008451Phase 4Recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Oct 2015
- Countries
- 1
01
Overview
Phase 4, open-label trial of Xingnaojing in ischemic stroke (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: compliance. Started Oct 2015; status: recruiting.
02
Drugs
Xingnaojing
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR-OPC-16008451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-16008451.